Chemo India Formulations Pvt. Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. 2B & 2C, Biotech Park – Phase II, Lalgadi Malakpet, Hyderabad, Telangana 500101, India (IND)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3017754175 · DUNS 877269056
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2024-11-22
Drugs this plant is listed as making
2 distinct drugs across 5 products name this site in their FDA label.
- Guanfacine HydrochlorideNorthstar Rx Llc
- RamelteonXiromed, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.